Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 2,485 | 3,029 | 3,245 | 3,576 | 3,092 |
| Cost of Goods | 2,221 | 2,673 | 2,738 | 2,867 | 2,625 |
| Gross Profit | 264 | 356 | 508 | 709 | 468 |
| Operating Expenses | 623 | 994 | 1,044 | 1,203 | 952 |
| Operating Income | -138 | 35 | 201 | 373 | 140 |
| Other Income | -2 | -3 | -4 | -2 | -4 |
| Pre-tax Income | -140 | 31 | 197 | 371 | 137 |
| Income Tax | -2 | 14 | 108 | 75 | 108 |
| Net Income Continuous | -139 | 17 | 89 | 295 | 28 |
| Net Income | $-139 | $17 | $89 | $295 | $28 |
| EPS Basic Total Ops | -0.03 | 0.00 | 0.36 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.01 | 0.06 | 0.21 | 0.02 |
| EPS Diluted Total Ops | -0.03 | 0.00 | 0.36 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.01 | 0.06 | 0.21 | 0.02 |
| EBITDA(a) | $-111 | $61 | $228 | $400 | $180 |